Company Profile
Kyongbo Pharmaceutical manufactures and sells active pharmaceutical ingredients and finished drugs in South Korea and globally. The company offers general, cephalosporins, and anti-cancer APIs.
Its portfolio also includes prescription drugs, including anesthetic, cardiovascular, digestive, and antibiotics, and OTC drugs, as well as medical devices, including portable X-ray machine and ultrasonic diagnostic equipment
Extraporeal shockwave therapy and temperature control PROBE. Additionally, it is involved in CDMO business; and R&D of Clopidogrel cardiovascular drug, Imatinlb anticancer drug, Donepezil anti-psychotic drug, Entecavir for anti-virus and infectious disease, and Esomeprazole.
It also exports its products. Founded in 1987 and headquartered in Asan-si, South Korea, Kyongbo Pharmaceutical was formerly known as Kyongbo Chemical Co. Ltd. before rebranding in March 2002.